By Tony Connelly

Reckitt Benckiser, the drug company that makes the painkiller Nurofen, is being investigated by the advertising watchdog over claims that it has misled consumers.

The British-based multinational company has been accused of making misleading claims across a number of its more expensive products marketed for specific complaints such as back pain or migraines.

Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache are marketed as formulated to treat a specific type of pain and cost almost double the price of standard Nurofen. However they were all found to contain the same active ingredient, 342mg of Ibuprofen lysine, equivalent Read full story ›

Source: The Drum